|1.||Fontenot, Andrew P: 8 articles (06/2014 - 04/2005)|
|2.||Amicosante, Massimo: 7 articles (09/2009 - 03/2004)|
|3.||Saltini, C: 6 articles (05/2004 - 03/2001)|
|4.||Falta, Michael T: 5 articles (06/2014 - 11/2005)|
|5.||Amicosante, M: 5 articles (05/2004 - 07/2001)|
|6.||Seto, Wai-Kay: 4 articles (03/2014 - 01/2013)|
|7.||Yuen, Man-Fung: 4 articles (03/2014 - 01/2013)|
|8.||Tanaka, Yasuhito: 4 articles (01/2014 - 01/2012)|
|9.||Taylor, Malcolm: 4 articles (01/2013 - 01/2008)|
|10.||Nakamura, Yusuke: 4 articles (10/2011 - 05/2009)|
08/01/2012 - "Both A alleles of HLA-DP SNP rs3077 and rs9277535 showed strong protective effects for spontaneous HBV clearance from persistent HBV infection in the Han Chinese population."
01/01/2012 - "These results suggest that the associations between the HLA-DP locus and the protective effects against persistent HBV infection and with clearance of HBV were replicated widely in East Asian populations; however, there are no reports of GWAS in Caucasian or African populations. "
01/01/2013 - "We aimed to study the association between HLA-DP SNPs and HBV infection and disease activity in the Chinese population of Hong Kong. "
12/01/2015 - "Fine mapping analysis of HLA-DP/DQ gene clusters on chromosome 6 reveals multiple susceptibility loci for HBV infection."
03/01/2015 - "In addition, Uygurs have higher frequencies of HLA-DP/DQ protective alleles (72.5% for rs3077, 76.6% for rs9277535 and 26.8% for rs7453920) than Tibetans (51.7% for rs3077, 52.5% for rs9277535 and 18.5% for rs7453920)(all P < 0.05), and a lower prevalence of HBV infection as previously reported. "
|2.||Chronic Hepatitis B
01/01/2012 - "Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean."
01/01/2014 - "Previous studies showed that single nucleotide polymorphisms (SNPs) in the HLA-DP, TCF19 and EHMT2 genes may affect the chronic hepatitis B (CHB). "
10/01/2014 - "In this large cohort of Caucasian chronic hepatitis B patients infected with HBV genotypes A or D, polymorphisms of HLA-DP are independently associated with both virological and serological response to PEG-IFN therapy at 6 months post-treatment."
10/01/2014 - "To investigate the association of HLA-DP polymorphisms with response to peginterferon (PEG-IFN) in Caucasian chronic hepatitis B (CHB) patients. "
10/01/2014 - "Polymorphisms of HLA-DP are associated with response to peginterferon in Caucasian patients with chronic hepatitis B."
01/01/2013 - "Role of HLA-DP polymorphisms on chronicity and disease activity of hepatitis B infection in Southern Chinese."
12/01/2012 - "HLA-DP gene polymorphisms and hepatitis B infection in the Japanese population."
01/01/2011 - "A recent genome-wide scan has identified two genetic variants in the HLA-DP region strongly associated with hepatitis B infection in Japanese. "
09/01/2014 - "Effect of HLA-DP and IL28B gene polymorphisms on response to interferon treatment in hepatitis B e-antigen seropositive chronic hepatitis B patients."
10/01/2014 - "Many GWASs conclude that the genetic variants in the HLA region (HLA-DP, HLA-DQ, HLA-DR and MICA), KIF1B, DEPDC5 and PNPLA3 influence HBV infection, its clinical course and the response to hepatitis B vaccination. "
11/01/2013 - "In conclusion, HLA-DP polymorphisms affect genotype B HBV clearance, regulate immune selection of viral mutations, and influence cirrhosis and HCC risks contributed by HBV mutations. "
11/01/2013 - "The interactions of C1653T, T1674C/G, and G1896A mutations with HLA-DP polymorphisms promoting HBV clearance significantly decreased cirrhosis risk. "
11/01/2013 - "Significant effects of viral mutations on cirrhosis and HCC were selectively evident in those with HLA-DP polymorphisms promoting HBV persistence. "
10/01/2014 - "To investigate the genetic association between cirrhosis and polymorphisms in the genes encoding major histocompatibility complex, class II (HLA)-DR beta 1 (DRB1) and HLA-DP beta 1 (DPB1). "
03/01/1999 - "HLA-DR-DQ alleles and HLA-DP alleles are independently associated with susceptibility to different stages of post-schistosomal hepatic fibrosis in the Chinese population."
11/01/1999 - "During the last years immunohistochemical techniques have improved the diagnosis of myocarditis using specific markers for quantification of leucocytes and characterization of T-lymphocytes together with the definition of MHC class II Antigens (HLA-DP, DQ, DR), known to be enhanced in cases of myocarditis. "
11/01/1999 - "The subsequent definition of the major histocompatibility complex class II antigens (HLA-DP,DQ,DR and HLA-DR), known to be enhanced in cases of myocarditis, the quantification of leucocytes with leucocyte common antigen (LCA) and characterization and quantification of T-lymphocytes using a specific marker (CD-3) allowed the definite diagnosis of myocarditis in three additional cases, six cases were found with moderate changes and ten cases without signs of inflammation."
08/01/1991 - "There was an expression of class II antigens (HLA-DR, HLA-DP, HLA-DQ) in acute rejection and in myocarditis and in some patients with dilated cardiomyopathy on endothelial cells, interstitial cells but not on the myocytes. "
|2.||HLA-DR Antigens (HLA-DR)
|3.||HLA-DQ Antigens (HLA-DQ)
|4.||Histocompatibility Antigens Class II
|5.||HLA-DPB1 (HLA DPB1)
|6.||Hepatitis B Surface Antigens (HBsAg)
|7.||HLA-DPA1 (HLA DPA1)
|8.||HLA-C Antigens (HLA-C)
|2.||Bone Marrow Transplantation (Transplantation, Bone Marrow)
|3.||Transplantation (Transplant Recipients)
|4.||Stem Cell Transplantation
|5.||Hematopoietic Stem Cell Transplantation